MALAT1 and neuroblastoma: In turn, Koshimizu et al. [46] reported that during neuroblastoma development, MALAT1 expression is sensitive to the activation of oxytocin cell surface receptors, and this induction of gene expression probably occurs through the cyclic AMP-responsive element binding (CREB) transcription factor, the binding site for which was identified in the MALAT1 promoter.